Ohenga Jackson W., K'Omollo Jasper W, Ochieng J
Alupe Leprosy and Skin Diseases Research Centre, Kenya Medical Research Institute P. O. Box 3, Busia, Kenya.
Afr J Health Sci. 1994 May;1(2):88-92.
A retrospective study of leprosy complications among new cases recruited for multiple drug therapy (MDT) at Alupe Leprosy Hospital between January 1986 and January 1992 was carried out to determine their prevalence, incidence and their relationship with disease classification. Out of 154 cases studied majority fell in the Borderline tuberculoid (BT) class (47%). The total follow up period was 186 person years giving an overall incidence rate of reactions of 20 per 100 person years. Overall point prevalence of complications for both males and females were highest in the extremities and ranged between 10% and 46% while the overall period prevalence ranged between 14% and 73% per year. There was a significant number of incident cases of complications during the follow-up period and comparison of different complications with different disease classes had odds ratios of around unity showing that MDT alone as an intervention measure plays no significant role in onset or progress of leprosy complications. It is observed that Borderline tuberculoid (BT) and Borderline lepromatous (BL) leprosy patients are at the highest risk of developing leprosy complications.
对1986年1月至1992年1月在阿卢佩麻风病医院招募接受多药联合治疗(MDT)的新病例中的麻风病并发症进行了一项回顾性研究,以确定其患病率、发病率及其与疾病分类的关系。在154例研究病例中,大多数属于界线类偏结核样型(BT)(47%)。总随访期为186人年,反应的总体发病率为每100人年20例。男性和女性并发症的总体时点患病率在四肢最高,范围在10%至46%之间,而总体期间患病率每年在14%至73%之间。随访期间有大量并发症的新发病例,不同并发症与不同疾病类别的比较的比值比约为1,这表明单纯MDT作为一种干预措施在麻风病并发症的发生或进展中不起重要作用。据观察,界线类偏结核样型(BT)和界线类偏瘤型(BL)麻风病患者发生麻风病并发症的风险最高。